The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The product is expected to start contributing meaningfully to the revenue from FY25
Subscribe To Our Newsletter & Stay Updated